Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

President Donald Trump signs a sweeping executive order aimed at drastically reducing prescription drug prices in the United ...

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an executive order aimed at reducing the cost of prescripti ...

Blue-chip health insurer UnitedHealth (UNH) is weighing on the Dow today after a suspended guidance and C-suite shakeup ...

Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) ...

UnitedHealth said Tuesday that Stephen J. Hemsley would take over as chief executive, effective immediately, as it suspended ...

Witty will act as a senior advisor to his successor, Stephen Hemsley, who served as UnitedHealth Group's CEO from 2006 to ...

UnitedHealth Group announced the surprise exit of CEO Andrew Witty on Tuesday and suspended its 2025 forecast due to surging ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...